428 related articles for article (PubMed ID: 38044048)
41. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
42. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
[TBL] [Abstract][Full Text] [Related]
43. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
44. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
45. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
[TBL] [Abstract][Full Text] [Related]
46. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
Dellinger RP; Levy MM; Carlet JM; Bion J; Parker MM; Jaeschke R; Reinhart K; Angus DC; Brun-Buisson C; Beale R; Calandra T; Dhainaut JF; Gerlach H; Harvey M; Marini JJ; Marshall J; Ranieri M; Ramsay G; Sevransky J; Thompson BT; Townsend S; Vender JS; Zimmerman JL; Vincent JL; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Crit Care Med; 2008 Jan; 36(1):296-327. PubMed ID: 18158437
[TBL] [Abstract][Full Text] [Related]
47. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.
Vergis N; Phillips R; Cornelius V; Katsarou A; Youngstein T; Cook L; Willicombe M; Pilay C; Shturova T; Almonte M; Charania A; Turner R; Kon OM; Cooke G; Thursz M; Cherlin S; Wason J; Milojkovic D; Innes AJ; Cooper N
Trials; 2021 Apr; 22(1):270. PubMed ID: 33845867
[TBL] [Abstract][Full Text] [Related]
48. COVID-19 Vaccine-Associated Pneumonitis in the Republic of Korea: A Nationwide Multicenter Survey.
Yoo H; Kim SY; Park MS; Jeong SH; Park SW; Lee HL; Lee HK; Yang SH; Jegal Y; Yoo JW; Lee J; Kang HK; Choi SM; Park J; Kim YW; Song JW; Park JH; Choi WI; Choi HS; Park C; Park JW; Chung MP
J Korean Med Sci; 2023 Apr; 38(14):e106. PubMed ID: 37038643
[TBL] [Abstract][Full Text] [Related]
49. Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer.
Enomoto Y; Inui N; Kato T; Baba T; Karayama M; Nakamura Y; Ogura T; Suda T
Lung Cancer; 2016 Jun; 96():63-7. PubMed ID: 27133752
[TBL] [Abstract][Full Text] [Related]
50. Otitis media with effusion.
; ;
Pediatrics; 2004 May; 113(5):1412-29. PubMed ID: 15121966
[TBL] [Abstract][Full Text] [Related]
51. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
[TBL] [Abstract][Full Text] [Related]
52. A living WHO guideline on drugs for covid-19.
Agarwal A; Hunt B; Stegemann M; Rochwerg B; Lamontagne F; Siemieniuk RA; Agoritsas T; Askie L; Lytvyn L; Leo YS; Macdonald H; Zeng L; Alhadyan A; Muna A; Amin W; da Silva ARA; Aryal D; Barragan FAJ; Bausch FJ; Burhan E; Calfee CS; Cecconi M; Chacko B; Chanda D; Dat VQ; De Sutter A; Du B; Freedman S; Geduld H; Gee P; Haider M; Gotte M; Harley N; Hashimi M; Hui D; Ismail M; Jehan F; Kabra SK; Kanda S; Kim YJ; Kissoon N; Krishna S; Kuppalli K; Kwizera A; Lado Castro-Rial M; Lisboa T; Lodha R; Mahaka I; Manai H; Mendelson M; Migliori GB; Mino G; Nsutebu E; Peter J; Preller J; Pshenichnaya N; Qadir N; Ranganathan SS; Relan P; Rylance J; Sabzwari S; Sarin R; Shankar-Hari M; Sharland M; Shen Y; Souza JP; Swanstrom R; Tshokey T; Ugarte S; Uyeki T; Evangelina VC; Venkatapuram S; Vuyiseka D; Wijewickrama A; Tran L; Zeraatkar D; Bartoszko JJ; Ge L; Brignardello-Petersen R; Owen A; Guyatt G; Diaz J; Kawano-Dourado L; Jacobs M; Vandvik PO
BMJ; 2020 Sep; 370():m3379. PubMed ID: 32887691
[TBL] [Abstract][Full Text] [Related]
53. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
National Immunization Advisory Committee Technical Working Group
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
[TBL] [Abstract][Full Text] [Related]
54. Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel Report.
Birring SS; Kavanagh JE; Irwin RS; Keogh KA; Lim KG; Ryu JH;
Chest; 2018 Oct; 154(4):904-917. PubMed ID: 30036496
[TBL] [Abstract][Full Text] [Related]
55. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
57. [Management of COVID-19: the Zhejiang experience].
Xu K; Cai H; Shen Y; Ni Q; Chen Y; Hu S; Li J; Wang H; Yu L; Huang H; Qiu Y; Wei G; Fang Q; Zhou J; Sheng J; Liang T; Li L
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Feb; 49(2):147-157. PubMed ID: 32391658
[TBL] [Abstract][Full Text] [Related]
58. A Delphi consensus statement for the management of post-COVID interstitial lung disease.
Hadda V; Suri TM; Iyer H; Jain A; Mittal S; Madan K; Mohan A; Seith Bhalla A; Sindhwani G; Dutt N; Venkatnarayan K; Nath A; Dhooria S; Kumar R; Marwah V; Karmakar S; Chaudhry D; Ayub II; Dwivedi DP; Tiwari P; Koul P; Behera AK; Saxena P; Sengupta A; Mohapatra PR; Goyal A; Christopher DJ; Guleria R
Expert Rev Respir Med; 2022 Sep; 16(9):983-995. PubMed ID: 36154545
[TBL] [Abstract][Full Text] [Related]
59. Retrospective comparative study of the efficacy of JAK inhibitor (tofacitinib) in the treatment of systemic sclerosis-associated interstitial lung disease.
Junfei Z; Meihua G; Shuai Z; Xiangting L; Zhidan L; Tianming C; Yajing L; Chu T; Lipu S
Clin Rheumatol; 2023 Oct; 42(10):2823-2832. PubMed ID: 37335409
[TBL] [Abstract][Full Text] [Related]
60. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
Quintana-Ortega C; Remesal A; Ruiz de Valbuena M; de la Serna O; Laplaza-González M; Álvarez-Rojas E; Udaondo C; Alcobendas R; Murias S
Mod Rheumatol Case Rep; 2021 Jan; 5(1):101-107. PubMed ID: 33019894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
